The sacroiliac (SI) joint, located at the bottom end of the spine, facilitates motion and transmits forces between the lower back and pelvis. Sacroiliac joint dysfunction causes pain around the lower back, hips, and groin areas. Sacroiliac joint fusion is a minimally-invasive surgical procedure used to treat chronic sacroiliac joint pain by immobilizing the affected joint. The procedure involves placing screws, rods, or other implants across the joint to fuse the joint and restrict its movement. It provides relief by eliminating motion and transferring stress away from the painful SI joint.
The global sacroiliac joint fusion market size is expected to reach US$ 1,525.1 Mn by 2030, from US$ 625.3 Mn in 2023, at a CAGR of 13.6% during the forecast period.
Key Takeaways
Key players operating in the Global Sacroiliac Joint Fusion market are SI-BONE, Medtronic, Zimmer Biomet, Globus Medical, and Orthofix. SI-BONE dominates the market with its iFuse Implant System.
The rising prevalence of spinal disorders due to sedentary lifestyles and obesity is fueling the demand for Global Sacroiliac Joint Fusion Market. According to the National Institute of Neurological Disorders and Stroke, around 31 million Americans suffer from back pain at some point in their lives.
Technological advancements are helping improve clinical outcomes. New implant designs, materials, and navigation systems are making SI joint fusion procedures safer and more effective. Companies are also developing bioabsorbable implants that do not require follow-up surgery for removal.
Market Trends
Growth in Outpatient Procedures: More patients are opting for SI joint fusion as an outpatient procedure due to advancements in technology and surgical techniques that reduce recovery times. This is expected to drive the market's growth.
Rising Geriatric Population: The global aging population is increasing the risk of spinal conditions. According to the WHO, the number of people aged 65 years and above is projected to reach 1.5 billion by 2050. This will likely augment the demand for SI joint therapies.
Market Opportunities
Emerging Markets: Regions like Asia Pacific, Latin America, Middle East and Africa offer immense opportunities for sacroiliac joint fusion device manufacturers due to rising healthcare expenditures and improving access to quality care.
Combination Therapies: Companies are exploring opportunities to develop minimally-invasive solutions combining procedures like SI joint denervation with fusion to provide synergistic pain relief.
Impact of COVID-19 on Global Sacroiliac Joint Fusion Market
The COVID-19 pandemic had a significant impact on the global sacroiliac joint fusion market. During the initial outbreak, elective surgeries like sacroiliac joint fusion were postponed to avoid spreading the virus in hospitals and divert resources towards critical care of COVID-19 patients. This led to a steep decline in procedural volumes and revenues for sacroiliac joint fusion device manufacturers in 2020.
As the pandemic progressed, sacroiliac joint fusion procedures slowly resumed under strict safety protocols. However, patient visits to orthopedic clinics reduced significantly due to fear of virus exposure and travel restrictions. This impacted new patient evaluations and diagnosis of sacroiliac joint disorders, reducing the pipeline of potential fusion candidates. Telemedicine played a key role in continuing postoperative consultations and rehabilitation during this period.
With widespread vaccination drives in 2021, the sacroiliac joint fusion market is recovering. Procedure volumes are nearing pre-COVID levels as patient confidence in hospital safety rises. Industry experts expect the market to bounce back strongly through 2022. Manufacturers are focusing on easing surgery-related constraints through minimally invasive techniques and hybrid procedures. They are also expanding virtual training programs for surgeons to boost adoption. While short-term challenges remain from new virus variants, the long-term outlook for the sacroiliac joint fusion market is positive.
The United States accounts for the largest share of the global sacroiliac joint fusion market in terms of value. This is attributed to the high prevalence of sacroiliac joint disorders, advanced healthcare infrastructure and favorable reimbursement policies supporting fusion procedures. Growing awareness about minimally invasive SI joint treatments is also driving the US market.
Germany, France and the United Kingdom collectively form the second largest regional market for sacroiliac joint fusion. A rapidly aging population base and rising geriatric patient pool undergoing fusion for degenerative sacroiliitis are fueling market growth in these European countries. Asia Pacific region is expected to witness the fastest CAGR over the forecast period, led by China, Japan and India. This can be credited to increasing healthcare expenditures, availability of low-cost fusion devices and rising medical tourism.
Explore additional details from the source: The Global Sacroiliac Joint Fusion Market is booming driven by advancements in medical technology
Explore additional details from the source: The Global Sacroiliac Joint Fusion Market is driven by increasing adoption of minimally invasive techniques
Explore additional details from the source: Long Term Outlook of the Global Sacroiliac Joint Fusion Market
Explore additional details from the source: The Global Sacroiliac Joint Fusion Market is Anticipated to Witness High Growth Owing to Growing Cases of Lower Back Pain
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)